Paxman
49.90 SEK
-4.04 %
Less than 1K followers
PAX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Paxman
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 64.8 | 66.2 | 253.0 | 67.1 | 74.9 | 86.9 | 84.4 | 313.3 |
| EBITDA | 11.8 | 11.5 | 49.7 | 10.4 | 5.0 | 7.8 | 5.8 | 28.5 |
| EBIT | 8.5 | 7.0 | 33.5 | 6.2 | 0.6 | 1.0 | -3.0 | 4.3 |
| EBIT-% | 13.1 % | 10.6 % | 13.2 % | 9.2 % | 0.8 % | 1.1 % | -3.6 % | 1.4 % |
| Profit before taxes | 5.1 | 13.5 | 41.5 | -5.5 | -3.1 | 1.3 | -2.8 | -10.6 |
| Net income | 5.0 | 12.2 | 40.2 | -5.5 | -3.3 | 1.3 | -8.8 | -16.7 |